Filing Details

Accession Number:
0001181431-14-035181
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-31 18:38:37
Reporting Period:
2014-10-31
Filing Date:
2014-10-31
Accepted Time:
2014-10-31 18:38:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1487371 Genmark Diagnostics Inc. GNMK Surgical & Medical Instruments & Apparatus (3841) 272053069
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366268 Faiz Jon Kayyem 5964 La Place Court
Carlsbad CA 92008
Svp, Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-10-31 6,000 $11.01 82,934 No 4 S Indirect The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 61,651 Indirect HI Charitable Remainder Uni Trust
Common Stock 108,947 Direct
Common Stock 569,308 Indirect IFIN LP
Footnotes
  1. The sales reported in this Form 4 were the final sales to be effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012.
  2. This transaction was executed in multiple trades at prices ranging from $11.00 to $11.21. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the reported transactions were effected.
  3. Dr. Kayyem is the trustee of the HI Charitable Remainder Uni Trust, trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust, dated April 1, 2000 and the President of In-Motion LLC, the general partner of IFIN LP. Dr. Kayyem disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.